IP Verse

Hoffmann Eitle competitive analysis

Explore the latest publications and patents granted to Hoffmann Eitle, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Hoffmann Eitle against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3710128	Process For Separating A Mixture With Measurement Of Purity Or Yield On An Intermediate Tank	NOVASEP PROCESS	Jun 10, 2025
EP3800357	Heart Assist Device With Expandable Impeller Pump	TC	Feb 10, 2025
EP3848028	Methods Of Treating Ocular Conditions	OYSTER POINT PHARMA	Feb 6, 2025
EP3554581	Medical Injection Device Packaging	TEVA PHARMACEUTICALS	Dec 13, 2024
EP3723739	Isoxazoline Parasiticide Formulations And Methods For Treating Blepharitis	TARSUS PHARMACEUTICALS	Dec 12, 2024
EP3215640	Chromatographic Sequential Simulated Moving Bed Fractionation Method Of A Feedstock	DUPONT NUTRITION BIOSCIENCES APS	Oct 24, 2024
EP3695001	Process For Enzymatic Hydrolysis Of Lignocellulosic Material And Fermentation Of Sugars	DSM ASSETS	Oct 9, 2024
EP3744326	Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Sep 5, 2024
EP3782612	Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof	CELGENE	Aug 8, 2024
EP3701714	Conference System, Tool, And Peripheral Devices	GUANGZHOU SHIRUI ELECTRONICS	Jul 11, 2024

Discover the latest PTAB cases involving Hoffmann Eitle, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hoffmann Eitle with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
HOFFMANN EITLE	147	-	-	-	Highly Aggressive
CELGENE	-	65	-	11	Non-Active
GENENTECH	-	86	-	65	Non-Active
NOVARTIS	6	406	-	21	Defensive